Project Grant 90BISA0053

Award Date 6/1/22
Completion Date 11/30/22
Dollars Obligated $200K
Federal Grant Program
93.433
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
This Project Grant award of $220,947.00, provided by the National Science Foundation's Engineering program (CFDA 47.041), supports fundamental research to develop an intelligent wearable system that can assess patient motivation, adapt the challenge level of therapeutic activities, and cue stroke survivors to engage in prescribed exercises. The goal is to address the problem of "learned non-use", where stroke survivors refrain from using their impaired limbs despite retaining the...
This $750,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program will fund the development of appropriate rehabilitation technology for stroke survivors through passive tactile stimulation. The Leland Stanford Junior University will lead an interdisciplinary team including universities, hospitals, and community organizations to finalize the team composition, generate use cases, and develop a comprehensive research plan including initial...
This Project Grant award of $599,960 from the National Science Foundation's Engineering program (CFDA 47.041) will enhance the effectiveness and engagement of home-based hand rehabilitation through artificial intelligence (AI) and motion-sensing technology. The key products and services to be delivered under this 5-year award include: Developing a computer vision-based recovery monitoring system that integrates motion sensing and muscle activity data to model and visualize hand recovery...
Neurotechr3 Inc. received a $276,000 STTR Phase I Project Grant award from the National Science Foundation on May 1, 2021 to develop a customized upper extremity telerehabilitation solution. The solution will feature remote therapist interaction and dynamic motor recovery feedback for stroke patients. The award is funded under the NSF Directorate for Engineering's Engineering program (CFDA 47.041) to improve quality of life and economic strength through innovative engineering research and...
This $997,735 cooperative agreement from the National Science Foundation will support Neurotechr3 Inc.'s development of a personalized telerehabilitation solution for individuals recovering from stroke-related arm and hand impairments. The awardee will advance its machine learning-driven telerehabilitation system through new exergames, personalized rehabilitation plans synchronized with patient recovery trajectories, and clinical evaluations. The system aims to improve access to effective...
This Small Business Innovation Research (SBIR) Phase I project, funded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a bi-directional brain-computer interface (BCI) to support advanced neuroprosthetics and devices. The goal is to restore functional independence for individuals with paralysis and motor deficits. The $295,000 award will fund the creation of a Unity-based extended reality (XR) BCI development...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $613,744 to Assistive Technology Development Inc. to develop a lightweight, cost-effective robotic telerehabilitation device for patients with musculoskeletal conditions. The device will provide motorized exercise modes coupled with blood flow restriction to enhance the...
The National Institute on Aging (NIA) awarded a $1,901,570 Project Grant (CFDA 93.866 - Aging Research) to Flint Rehabilitation Devices, LLC to develop the MIGO TRACKER, a wearable exercise sensor and remote therapeutic monitoring (RTM) system for individuals recovering from stroke. The primary objectives are to: 1) complete MIGO TRACKER firmware development based on end-user feedback; 2) develop an online HIPAA-compliant RTM dashboard; and 3) conduct a randomized controlled trial to determine...
This $179,053 federal Project Grant awarded by the National Science Foundation's (NSF) Engineering program (CFDA 47.041) supports fundamental research to develop an intelligent wearable exercise reminder system called SOUVENIR. The system aims to assess patient motivation in real-time, adapt the challenge level of therapeutic activities, and provide personalized cues to improve compliance with post-stroke rehabilitation exercises. The project, led by Marquette University, will conduct...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $652,497 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to investigate the neurological substrates of proximal upper extremity motor control and recovery after stroke. The key objectives are to: (1) determine baseline relationships between the...

IW - BLUETOOTH ELECTROMYOGRAPHY-BASED STROKE THERAPEUTIC (BEST): SHIFTING THE PARADIGM WITH BIOFEEDBACK-DRIVEN HOME THERAPY - THIS IS A SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT. IMPULSE WELLNESS LLC (IW) WILL, THROUGHOUT THIS SIX-MONTH AWARD, RESEARCH AND DEVELOP THE BLUETOOTH ELECTROMYOGRAPHY-BASED STROKE THERAPEUTIC (BEST) WORKING PROTOTYPE. THE GOAL OF THIS PROPOSAL IS TO CREATE AN IMMERSIVE AND INTUITIVE STROKE REHABILITATION TOOL THAT HELPS FUNCTIONALLY IMPAIRED USERS TAKE A MORE ACTIVE ROLE IN THEIR RECOVERY. THE OBJECTIVES ARE IN LINE WITH NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATION RESEARCH'S (NIDILRR) MAJOR OUTCOME TWO, "HEALTH AND FUNCTION." DURING THE PROJECT'S INCEPTION, THE IW TEAM CONDUCTED AN EVALUATIVE STUDY (45 STROKE SURVIVORS AND CARE PROVIDERS) TO BRING TO LIGHT THE BARRIERS, FACILITATORS, AND UNTAPPED POTENTIAL OF REHABILITATIVE TECHNOLOGIES IN CLINICAL NEUROREHABILITATION AND TO FURTHER ENSURE THE NEEDS OF THIS TARGET POPULATION ARE MET. THROUGH A RIGOROUS SYSTEMATIC STUDY AND APPLICATION OF KNOWLEDGE, THE IW TEAM WILL CREATE AN INFORMATIVE STROKE THERAPEUTIC SYSTEM AND WILL DEVELOP THE HARDWARE, BIOFEEDBACK ALGORITHM, AND MOBILE APPLICATION. THE BEST BIOFEEDBACK SYSTEM WILL INCORPORATE STATE-OF-THE-ART EMBEDDED DRY ELECTRODES TO COLLECT SURFACE ELECTROMYOGRAPHY SIGNALS. IN USING OUR PROPRIETARY BIOFEEDBACK ALGORITHM AND APPLICATION, WE WILL PROVIDE USERS WITH MOTIVATIONAL, INDIVIDUALIZED, AND CLINICALLY MEANINGFUL RECOVERY INFORMATION, SUCH AS THE LEVEL OF COMMUNICATION BETWEEN A STROKE SURVIVOR'S AGONISTIC AND ANTAGONISTIC MUSCLES. IN PHASE II, WE WILL FURTHER TEST AND REFINE THE FUNCTIONAL PROTOTYPE BASED ON THE OUTCOMES OF THIS PROPOSED PHASE I RESEARCH AND DEVELOPMENT. THIS WILL BE STUDIED THROUGH ADDITIONAL RESEARCH OF THE KEY OBJECTIVES IN PHASE I, TESTING OF ADDITIONAL METRICS WHICH WILL BE SYSTEMATICALLY OPTIMIZED BASED ON THE KNOWLEDGE GAINED IN THE PHASE I WORK, AND RESEARCH OF THE CLINICAL IMPLICATIONS OF THE BEST SYSTEM. PHASE II WILL CULMINATE WITH A FUNCTIONAL PROTOTYPE THAT FEATURES INTERACTIVE TRAINING GAMES AND INDIVIDUALIZED BIOFEEDBACK RESULTS GARNERED FROM THE BEST SYSTEM. THE PHASE III GOALS WILL BE TO DEPLOY A MINIMUM VIABLE PRODUCT IN RESPONSE TO EXPERIENCES AND INFORMATION GAINED FROM THE PHASE I AND PHASE II RESEARCH AND DEVELOPMENTS WITH THE ANTICIPATED OUTCOMES OF INCREASED ACCESS TO AFFORDABLE STROKE REHABILITATION AND IMPROVED QUALITY OF LIFE FOR MOTOR IMPAIRED STROKE VICTIMS. WE WILL ALSO SHIFT THE TREATMENT PARADIGM FROM LOW REPETITION ON-SITE THERAPY TO A HIGH-DOSE MOTOR REPAIR INTERVENTION THAT IS PERFORMED IN THE COMFORT OF ONE'S OWN CHOOSING. THE EXPECTED PRODUCTS ARE A WEARABLE SYSTEM CONSISTING OF A MUSCLE-SENSING DEVICE AND A USER-FRIENDLY MOBILE BIOFEEDBACK APPLICATION THAT PROVIDE HIGH-QUALITY DIAGNOSTICS AND TRAINING GAMES. THIS SYSTEM WILL BE AN ENGAGING AND IMMERSIVE EXPERIENCE THAT WILL SPEED UP RECOVERY, FINE-TUNE USERS' MOTOR SKILLS, AND MORE RAPIDLY BRING STROKE SURVIVORS BACK TO THEIR "BEST" WHEN COMPARED TO TRADITIONAL THERAPIES.

Posted 5/31/22